Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Digestive System Diseases; Neoplasms | 0.800 | 0.971 | 34 | 2009 | 2019 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Digestive System Diseases; Neoplasms | 0.100 | 0.968 | 31 | 2009 | 2019 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.800 | 1.000 | 13 | 2009 | 2019 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.800 | 1.000 | 12 | 2009 | 2019 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.100 | 1.000 | 11 | 2009 | 2019 | ||||||
|
0.724 | 0.240 | 8 | 142681514 | 3 prime UTR variant | G/A | snv | 0.46 | 0.45 |
|
Digestive System Diseases; Neoplasms | 0.100 | 0.909 | 11 | 2009 | 2019 | ||||||
|
0.724 | 0.240 | 8 | 142681514 | 3 prime UTR variant | G/A | snv | 0.46 | 0.45 |
|
Digestive System Diseases; Neoplasms | 0.100 | 0.909 | 11 | 2009 | 2019 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Digestive System Diseases | 0.860 | 1.000 | 6 | 2012 | 2019 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Digestive System Diseases | 0.050 | 1.000 | 5 | 2014 | 2019 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.040 | 1.000 | 4 | 2010 | 2015 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2013 | 2014 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Digestive System Diseases | 0.720 | 1.000 | 3 | 2013 | 2019 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2015 | 2017 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Digestive System Diseases | 0.020 | 1.000 | 2 | 2015 | 2019 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Digestive System Diseases; Neoplasms | 0.710 | 1.000 | 2 | 2015 | 2015 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
0.020 | 1.000 | 2 | 2013 | 2016 | |||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2015 | 2017 | ||||||
|
0.724 | 0.240 | 8 | 142681514 | 3 prime UTR variant | G/A | snv | 0.46 | 0.45 |
|
Digestive System Diseases | 0.020 | 1.000 | 2 | 2014 | 2019 | ||||||
|
0.790 | 0.160 | 8 | 142670817 | intron variant | T/C;G | snv |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2012 | 2013 | ||||||||
|
0.790 | 0.160 | 8 | 142670817 | intron variant | T/C;G | snv |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2012 | 2013 | ||||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.672 | 0.320 | 8 | 142680513 | 5 prime UTR variant | C/T | snv | 0.46 | 0.45 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 |